Race Oncology, EZZ Life Science and Neurotech International are among ASX health companies reporting quarterly results.

Commenting on the collaboration, Ranjit Puranik, Managing Director of Shree Dhootapapeshwar Ltd, said, "We are pleased to have Shri Paresh Rawal on board as the face of Brand Swamala. His credibility, ...

Advances 5x30 strategy by expanding pipeline with a highly complementary asset that has the potential to provide several days ...

With the rise of “Protein Maxing” among biohackers, fitness influencers, and health-conscious consumers, a major controversy has emerged that ...

Delivered quarterly XDEMVY® net sales of approximately $119 million, up approximately 147% year-over-yearWeekly multi-patient ...

The Global Tube Packaging Market Size is projected to grow at a CAGR of 6.82% from 2026 to 2032, according to a new report ...

On November 5, SK Biopharm announced that it recorded third-quarter sales and operating profit that exceeded market expectations, driven by the rapid ...

AXPAXLI (TM) (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...

Datavault AI Inc. ("Datavault AI" or the "Company") , a leader in AI-driven blockchain solutions focusing on data monetization, asset tokenization, and secure digital marketplaces, today announced ...

Cash balance of $344.8 million as of September 30, 2025, together with net proceeds of ~$445 million from October 2025 equity offering, with expected runway into 2028 BEDFORD, Mass., Nov. 04, 2025 ...

Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced that it will participate in and present at four upcoming investor conferences during the remainder of this year. Members of ...